Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-13 | Mr. John Edward MeldrumExecutive Director | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-13 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | 35,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-03-30 | Mr. Michael James BellExecutive Chairman | 4,00k | 65,68k | Kauf | 16,42 | 3,18M | 0,13% |
| 2026-03-16 | Mr. Michael James BellExecutive Chairman | 5,30k | 94,39k | Kauf | 17,82 | 3,00M | 0,18% |
| 2026-03-16 | Mr. Michael James BellExecutive Chairman | -5,30k | 94,39k | Verkauf | 17,82 | 3,00M | -0,18% |
| 2026-02-20 | Mr. Michael Patrick Andrew O'ConnellMD & Executive Director | 4,37k | 74,35k | Kauf | 17,01 | 1,23M | 0,36% |
| 2026-02-20 | Mr. Michael Patrick Andrew O'ConnellMD & Executive Director | -4,37k | 74,31k | Verkauf | 17,00 | 1,23M | -0,35% |
| 2026-01-30 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-01-19 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | 101,00 | 1,72k | Kauf | 17,06 | 20,36k | 0,50% |
| 2026-01-19 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | -103,00 | 1,76k | Verkauf | 17,06 | 20,36k | -0,50% |
| 2026-01-19 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | -2,66k | 0,00 | Other Disposition | - | 20,36k | -11,57% |
| 2025-10-01 | Mr. Michael James BellExecutive Chairman | 6,67k | 12,67k | Derivative Exercise and Retained Stock | 1,90 | 3,00M | 0,22% |
| 2025-08-22 | Mr. Michael James BellExecutive Chairman | 202,00 | 3,39k | Kauf | 16,76 | 3,00M | 0,01% |
| 2025-09-09 | Mr. Michael James BellExecutive Chairman | 50,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,99M | 1,70% |
| 2025-08-22 | Mr. Michael James BellExecutive Chairman | 18,72k | 311,72k | Kauf | 16,65 | 2,94M | 0,64% |
| 2025-08-22 | Mr. Michael James BellExecutive Chairman | -18,72k | 311,68k | Verkauf | 16,65 | 2,94M | -0,63% |
| 2025-08-22 | Mr. Michael Patrick Andrew O'ConnellMD & Executive Director | 16,44k | 273,78k | Kauf | 16,65 | 1,07M | 1,56% |
| 2025-08-22 | Mr. Michael Patrick Andrew O'ConnellMD & Executive Director | -16,44k | 273,76k | Verkauf | 16,65 | 1,07M | -1,51% |
| 2025-08-13 | Mr. John Edward MeldrumExecutive Director | 6,67k | 12,75k | Derivative Exercise and Retained Stock | 1,91 | 18,52k | 56,22% |
| 2025-07-15 | Mr. Michael Patrick Andrew O'ConnellMD & Executive Director | 6,67k | 12,59k | Derivative Exercise and Retained Stock | 1,89 | 1,07M | 0,63% |
| 2025-07-15 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | -3,90k | 0,00 | Other Disposition | - | 20,36k | -16,08% |
| 2025-07-09 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | 1,65k | 25,37k | Kauf | 15,35 | 20,36k | 8,84% |
| 2025-07-09 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | -1,66k | 25,40k | Verkauf | 15,35 | 20,36k | -7,52% |
| 2025-07-02 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | 1,64k | 27,20k | Kauf | 16,61 | 20,36k | 8,75% |
| 2025-07-02 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | -1,64k | 27,24k | Verkauf | 16,61 | 20,36k | -7,45% |
| 2025-07-02 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | -1,66k | 0,00 | Other Disposition | - | 20,36k | -7,52% |
| 2025-07-01 | Ms. Shelley Louise AshcroftFinance Director, Company Secretary & Director | 6,67k | 12,88k | Derivative Exercise and Retained Stock | 1,93 | 20,36k | 48,67% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
